| - GRCh37:
- Chr17:67205220-81044553
- GRCh38:
- Chr17:69209079-83086677
| AANAT, AATK, ABCA10, ABCA5, ACOX1, ACTG1, AFMID, ALYREF, ANAPC11, ARHGDIA, ARL16, ARMC7, ASPSCR1, ATP5PD, B3GNTL1, BAHCC1, BAIAP2, BAIAP2-DT, BIRC5, BTBD17, C17orf80, C17orf99, C1QTNF1, C1QTNF1-AS1, CANT1, CARD14, CASC17, CASKIN2, CBX2, CBX4, CBX8, CCDC137, CCDC40, CCDC57, CD300A, CD300C, CD300E, CD300H, CD300LB, CD300LD, CD300LD-AS1, CD300LF, CD7, CDC42EP4, CDK3, CDR2L, CENPX, CEP131, CEP295NL, CHMP6, COG1, CPSF4L, CSNK1D, CYBC1, CYGB, CYTH1, DCXR, DCXR-DT, DNAH17, DNAH17-AS1, DNAI2, DUS1L, EIF4A3, ENDOV, ENGASE, ENPP7, EVPL, EXOC7, FAAP100, FADS6, FAM104A, FASN, FBF1, FDXR, FN3K, FN3KRP, FOXJ1, FOXK2, FSCN2, GAA, GALK1, GALR2, GCGR, GGA3, GPR142, GPRC5C, GPS1, GRB2, GRIN2C, H3-3B, HEXD, HEXD-IT1, HGS, HID1, HID1-AS1, ITGB4, JMJD6, JPT1, KCNJ16, KCNJ2, KCNJ2-AS1, KCTD2, KIF19, LGALS3BP, LINC00469, LINC00482, LINC00511, LINC00673, LINC00868, LINC01028, LINC01152, LINC01483, LINC01497, LINC01970, LINC01971, LINC01973, LINC01977, LINC01978, LINC01979, LINC01987, LINC01993, LINC02003, LINC02074, LINC02078, LINC02080, LINC02092, LINC02097, LINC03048, LLGL2, LOC100134391, LOC100507351, LOC101928251, LOC101928343, LOC101928855, LOC101929552, LOC102723517, LOC105274304, LOC105371880, LOC105371899, LOC105371910, LOC105371925, LOC108004545, LOC108004546, LOC108004547, LOC108004548, LOC108004549, LOC108004550, LOC108021839, LOC108021840, LOC108021842, LOC108021843, LOC108021844, LOC108021845, LOC108021846, LOC108254686, LOC108254691, LOC108281162, LOC108348028, LOC110121373, LOC110599586, LOC111413039, LOC111429614, LOC112268198, LOC112533666, LOC112533667, LOC112533668, LOC112533669, LOC112533670, LOC112533671, LOC112533672, LOC112533673, LOC112533674, LOC112533675, LOC112533676, LOC112533677, LOC112533678, LOC112533679, LOC112533680, LOC112533681, LOC112533682, LOC112533686, LOC112533687, LOC116276479, LOC116276480, LOC116276481, LOC116276482, LOC116276483, LOC116276484, LOC116276485, LOC121603772, LOC121603773, LOC121627807, LOC121627808, LOC121627809, LOC121627810, LOC121627811, LOC121627812, LOC121627813, LOC121627814, LOC121627815, LOC121627816, LOC121627817, LOC121627818, LOC121627819, LOC121627820, LOC121852949, LOC121852950, LOC121852951, LOC121852952, LOC121852953, LOC121852954, LOC121852955, LOC121852956, LOC121852957, LOC122455342, LOC125316786, LOC125316787, LOC125316788, LOC125316789, LOC125316790, LOC125316791, LOC125316792, LOC125316793, LOC125316794, LOC125316795, LOC125316796, LOC125316797, LOC125316798, LOC125316799, LOC125316800, LOC125316801, LOC125316802, LOC125316804, LOC125316805, LOC125316806, LOC125316807, LOC125316808, LOC125316809, LOC125316810, LOC125316811, LOC125316812, LOC125316813, LOC125316814, LOC125316815, LOC125316816, LOC125316817, LOC125316818, LOC125316819, LOC125316821, LOC125316822, LOC125316823, LOC126862624, LOC126862625, LOC126862626, LOC126862627, LOC126862628, LOC126862629, LOC126862630, LOC126862631, LOC126862632, LOC126862633, LOC126862634, LOC126862635, LOC126862636, LOC126862637, LOC126862638, LOC126862639, LOC126862640, LOC126862641, LOC126862642, LOC126862643, LOC126862644, LOC126862645, LOC126862646, LOC126862647, LOC126862648, LOC126862649, LOC126862650, LOC126862651, LOC126862652, LOC126862653, LOC126862654, LOC126862655, LOC126862656, LOC126862657, LOC126862658, LOC126862659, LOC126862660, LOC126862661, LOC126862662, LOC126862663, LOC126862664, LOC126862665, LOC126862666, LOC126862667, LOC126862668, LOC126862669, LOC126862670, LOC126862671, LOC126862672, LOC126862673, LOC126862674, LOC400622, LOC400627, LRRC45, MAFG, MAP2K6, MCRIP1, METRNL, METTL23, MFSD11, MGAT5B, MGC16275, MIF4GD, MIF4GD-DT, MILIP, MIR1250, MIR1268B, MIR3065, MIR3186, MIR338, MIR3615, MIR3678, MIR4316, MIR4525, MIR4730, MIR4738, MIR4739, MIR4740, MIR636, MIR6516, MIR657, MIR6785, MIR6786, MIR6787, MIR6868, MRPL12, MRPL38, MRPL58, MRPS7, MXRA7, MYADML2, MYO15B, NARF, NARF-AS2, NAT9, NDUFAF8, NHERF1, NOTUM, NPB, NPLOC4, NPTX1, NT5C, NUP85, OGFOD3, OTOP2, OTOP3, OXLD1, P4HB, PCYT2, PDE6G, PGS1, PPP1R27, PRCD, PRO1804, PRPSAP1, PVALEF, PYCR1, QRICH2, RAB37, RAB40B, RAC3, RBFOX3, RECQL5, RFNG, RHBDF2, RNF157, RNF157-AS1, RNF213, RNF213-AS1, ROCR, RPL38, RPTOR, SAP30BP, SCARNA16, SCAT1, SDK2, SEC14L1, SECTM1, SEPTIN9, SEPTIN9-DT, SGSH, SIRT7, SLC16A3, SLC16A5, SLC25A10, SLC25A19, SLC26A11, SLC38A10, SLC39A11, SLC9A3R1-AS1, SMIM5, SMIM6, SNHG16, SNHG20, SNORD134, SNORD1A, SNORD1B, SNORD1C, SOCS3, SOCS3-DT, SOX9, SOX9-AS1, SOX9CRE1, SPHK1, SRP68, SRSF2, SSTR2, ST6GALNAC1, ST6GALNAC2, SUMO2, SYNGR2, TBC1D16, TBCD, TEN1, TEN1-CDK3, TEPSIN, TEX19, TIMP2, TK1, TMC6, TMC8, TMEM104, TMEM105, TMEM235, TMEM94, TNRC6C, TNRC6C-AS1, TRIM47, TRIM65, TRR-CCT1-1, TRR-CCT2-1, TRR-TCG3-1, TRX-CAT1-8, TSEN54, TSPAN10, TTYH2, UBALD2, UBE2O, UNC13D, UNK, USH1G, USP36, UTS2R, WBP2, WDR45B, ZACN, ZNF750 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr17:67912576-81048189
- GRCh38:
- Chr17:69916435-83102552
| GALK1, GALR2, GCGR, GGA3, GPR142, GPRC5C, GPS1, GRB2, GRIN2C, H3-3B, HEXD, HEXD-IT1, HGS, HID1, HID1-AS1, ITGB4, JMJD6, JPT1, KCNJ16, KCNJ2, KCNJ2-AS1, KCTD2, KIF19, LGALS3BP, LINC00469, LINC00482, LINC00511, LINC00673, LINC00868, LINC01028, LINC01152, LINC01497, LINC01970, LINC01971, LINC01973, LINC01977, LINC01978, LINC01979, LINC01987, LINC01993, LINC02003, LINC02074, LINC02078, LINC02080, LINC02092, LINC02097, LINC03048, LLGL2, LOC100134391, LOC100507351, LOC101928251, LOC101928343, LOC101928855, LOC101929552, LOC102723517, LOC105274304, LOC105371899, LOC105371910, LOC105371925, LOC108004545, LOC108004546, LOC108004547, LOC108004548, LOC108004549, LOC108004550, LOC108021839, LOC108021840, LOC108021842, LOC108021843, LOC108021844, LOC108021845, LOC108021846, LOC108254686, LOC108254691, LOC108281162, LOC108348028, LOC110121373, LOC110599586, LOC111413039, LOC111429614, LOC112268198, LOC112533666, LOC112533667, LOC112533668, LOC112533669, LOC112533670, LOC112533671, LOC112533672, LOC112533673, LOC112533674, LOC112533675, LOC112533676, LOC112533677, LOC112533678, LOC112533679, LOC112533680, LOC112533681, LOC112533682, LOC112533686, LOC112533687, LOC116276479, LOC116276480, LOC116276481, LOC116276482, LOC116276483, LOC116276484, LOC116276485, LOC121603772, LOC121603773, LOC121627807, LOC121627808, LOC121627809, LOC121627810, LOC121627811, LOC121627812, LOC121627813, LOC121627814, LOC121627815, LOC121627816, LOC121627817, LOC121627818, LOC121627819, LOC121627820, LOC121852949, LOC121852950, LOC121852951, LOC121852952, LOC121852953, LOC121852954, LOC121852955, LOC121852956, LOC121852957, LOC122455342, LOC125316787, LOC125316788, LOC125316789, LOC125316790, LOC125316791, LOC125316792, LOC125316793, LOC125316794, LOC125316795, LOC125316796, LOC125316797, LOC125316798, LOC125316799, LOC125316800, LOC125316801, LOC125316802, LOC125316804, LOC125316805, LOC125316806, LOC125316807, LOC125316808, LOC125316809, LOC125316810, LOC125316811, LOC125316812, LOC125316813, LOC125316814, LOC125316815, LOC125316816, LOC125316817, LOC125316818, LOC125316819, LOC125316821, LOC125316822, LOC125316823, LOC126862626, LOC126862627, LOC126862628, LOC126862629, LOC126862630, LOC126862631, LOC126862632, LOC126862633, LOC126862634, LOC126862635, LOC126862636, LOC126862637, LOC126862638, LOC126862639, LOC126862640, LOC126862641, LOC126862642, LOC126862643, LOC126862644, LOC126862645, LOC126862646, LOC126862647, LOC126862648, LOC126862649, LOC126862650, LOC126862651, LOC126862652, LOC126862653, LOC126862654, LOC126862655, LOC126862656, LOC126862657, LOC126862658, LOC126862659, LOC126862660, LOC126862661, LOC126862662, LOC126862663, LOC126862664, LOC126862665, LOC126862666, LOC126862667, LOC126862668, LOC126862669, LOC126862670, LOC126862671, LOC126862672, LOC126862673, LOC126862674, LOC400622, LOC400627, LRRC45, MAFG, MCRIP1, METRNL, METTL23, MFSD11, MGAT5B, MGC16275, MIF4GD, MIF4GD-DT, MILIP, MIR1250, MIR1268B, MIR3065, MIR3186, MIR338, MIR3615, MIR3678, MIR4316, MIR4525, MIR4730, MIR4738, MIR4739, MIR4740, MIR636, MIR6516, MIR657, MIR6785, MIR6786, MIR6787, MIR6868, MRPL12, MRPL38, MRPL58, MRPS7, MXRA7, MYADML2, MYO15B, NARF, NARF-AS2, NAT9, NDUFAF8, NHERF1, NOTUM, NPB, NPLOC4, NPTX1, NT5C, NUP85, OGFOD3, OTOP2, OTOP3, OXLD1, P4HB, PCYT2, PDE6G, PGS1, PPP1R27, PRCD, PRPSAP1, PVALEF, PYCR1, QRICH2, RAB37, RAB40B, RAC3, RBFOX3, RECQL5, RFNG, RHBDF2, RNF157, RNF157-AS1, RNF213, RNF213-AS1, ROCR, RPL38, RPTOR, SAP30BP, SCARNA16, SCAT1, SDK2, SEC14L1, SECTM1, SEPTIN9, SEPTIN9-DT, SGSH, SIRT7, SLC16A3, SLC16A5, SLC25A10, SLC25A19, SLC26A11, SLC38A10, SLC39A11, SLC9A3R1-AS1, SMIM5, SMIM6, SNHG16, SNHG20, SNORD134, SNORD1A, SNORD1B, SNORD1C, SOCS3, SOCS3-DT, SOX9, SOX9-AS1, SOX9CRE1, SPHK1, SRP68, SRSF2, SSTR2, ST6GALNAC1, ST6GALNAC2, SUMO2, SYNGR2, TBC1D16, TBCD, TEN1, TEN1-CDK3, TEPSIN, TEX19, TIMP2, TK1, TMC6, TMC8, TMEM104, TMEM105, TMEM235, TMEM94, TNRC6C, TNRC6C-AS1, TRIM47, TRIM65, TRR-CCT1-1, TRR-CCT2-1, TRR-TCG3-1, TRX-CAT1-8, TSEN54, TSPAN10, TTYH2, UBALD2, UBE2O, UNC13D, UNK, USH1G, USP36, UTS2R, WBP2, WDR45B, ZACN, ZNF750, AANAT, AATK, ACOX1, ACTG1, AFMID, ALYREF, ANAPC11, ARHGDIA, ARL16, ARMC7, ASPSCR1, ATP5PD, B3GNTL1, BAHCC1, BAIAP2, BAIAP2-DT, BIRC5, BTBD17, C17orf80, C17orf99, C1QTNF1, C1QTNF1-AS1, CANT1, CARD14, CASC17, CASKIN2, CBX2, CBX4, CBX8, CCDC137, CCDC40, CCDC57, CD300A, CD300C, CD300E, CD300H, CD300LB, CD300LD, CD300LD-AS1, CD300LF, CD7, CDC42EP4, CDK3, CDR2L, CENPX, CEP131, CEP295NL, CHMP6, COG1, CPSF4L, CSNK1D, CYBC1, CYGB, CYTH1, DCXR, DCXR-DT, DNAH17, DNAH17-AS1, DNAI2, DUS1L, EIF4A3, ENDOV, ENGASE, ENPP7, EVPL, EXOC7, FAAP100, FADS6, FAM104A, FASN, FBF1, FDXR, FN3K, FN3KRP, FOXJ1, FOXK2, FSCN2, GAA | | See cases | Pathogenic (Oct 23, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr17:76088317-81044553
- GRCh38:
- Chr17:78092236-83086677
| AATK, ACTG1, AFMID, ALYREF, ANAPC11, ARHGDIA, ARL16, ASPSCR1, B3GNTL1, BAHCC1, BAIAP2, BAIAP2-DT, BIRC5, C17orf99, C1QTNF1, C1QTNF1-AS1, CANT1, CARD14, CBX2, CBX4, CBX8, CCDC137, CCDC40, CCDC57, CD7, CENPX, CEP131, CEP295NL, CHMP6, CSNK1D, CYBC1, CYTH1, DCXR, DCXR-DT, DNAH17, DNAH17-AS1, DUS1L, EIF4A3, ENDOV, ENGASE, ENPP7, FAAP100, FASN, FN3K, FN3KRP, FOXK2, FSCN2, GAA, GCGR, GPS1, HEXD, HEXD-IT1, HGS, LGALS3BP, LINC00482, LINC01970, LINC01971, LINC01977, LINC01978, LINC01979, LINC01993, LINC02078, LINC03048, LOC101928855, LOC101929552, LOC105371910, LOC105371925, LOC108254691, LOC108281162, LOC108348028, LOC110599586, LOC112533674, LOC112533675, LOC112533676, LOC112533677, LOC112533678, LOC112533679, LOC112533680, LOC112533681, LOC112533682, LOC112533686, LOC112533687, LOC116276480, LOC116276481, LOC116276482, LOC116276483, LOC116276484, LOC116276485, LOC121627814, LOC121627815, LOC121627816, LOC121627817, LOC121627818, LOC121627819, LOC121627820, LOC121852953, LOC121852954, LOC121852955, LOC121852956, LOC121852957, LOC125316806, LOC125316807, LOC125316808, LOC125316809, LOC125316810, LOC125316811, LOC125316812, LOC125316813, LOC125316814, LOC125316815, LOC125316816, LOC125316817, LOC125316818, LOC125316819, LOC125316821, LOC125316822, LOC125316823, LOC126862653, LOC126862654, LOC126862655, LOC126862656, LOC126862657, LOC126862658, LOC126862659, LOC126862660, LOC126862661, LOC126862662, LOC126862663, LOC126862664, LOC126862665, LOC126862666, LOC126862667, LOC126862668, LOC126862669, LOC126862670, LOC126862671, LOC126862672, LOC126862673, LOC126862674, LOC400627, LRRC45, MAFG, MCRIP1, METRNL, MILIP, MIR1250, MIR1268B, MIR3065, MIR3186, MIR338, MIR4525, MIR4730, MIR4739, MIR4740, MIR657, MIR6786, MIR6787, MRPL12, MYADML2, NARF, NARF-AS2, NDUFAF8, NOTUM, NPB, NPLOC4, NPTX1, OGFOD3, OXLD1, P4HB, PCYT2, PDE6G, PGS1, PPP1R27, PVALEF, PYCR1, RAB40B, RAC3, RBFOX3, RFNG, RNF213, RNF213-AS1, RPTOR, SCAT1, SECTM1, SGSH, SIRT7, SLC16A3, SLC25A10, SLC26A11, SLC38A10, SNORD134, SOCS3, SOCS3-DT, SYNGR2, TBC1D16, TBCD, TEPSIN, TEX19, TIMP2, TK1, TMC6, TMC8, TMEM105, TMEM235, TNRC6C, TNRC6C-AS1, TRX-CAT1-8, TSPAN10, USP36, UTS2R, WDR45B, ZNF750 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr17:76898041-81044553
- GRCh38:
- Chr17:78901959-83086677
| AATK, ACTG1, ALYREF, ANAPC11, ARHGDIA, ARL16, ASPSCR1, B3GNTL1, BAHCC1, BAIAP2, BAIAP2-DT, C1QTNF1, C1QTNF1-AS1, CANT1, CARD14, CBX2, CBX4, CBX8, CCDC137, CCDC40, CCDC57, CD7, CENPX, CEP131, CEP295NL, CHMP6, CSNK1D, CYBC1, DCXR, DCXR-DT, DUS1L, EIF4A3, ENDOV, ENGASE, ENPP7, FAAP100, FASN, FN3K, FN3KRP, FOXK2, FSCN2, GAA, GCGR, GPS1, HEXD, HEXD-IT1, HGS, LGALS3BP, LINC00482, LINC01970, LINC01971, LINC01977, LINC01978, LINC01979, LINC02078, LINC03048, LOC101928855, LOC101929552, LOC105371925, LOC108254691, LOC108281162, LOC108348028, LOC112533676, LOC112533677, LOC112533678, LOC112533679, LOC112533680, LOC112533681, LOC112533682, LOC112533686, LOC112533687, LOC116276483, LOC116276484, LOC116276485, LOC121627816, LOC121627817, LOC121627818, LOC121627819, LOC121627820, LOC121852953, LOC121852954, LOC121852955, LOC121852956, LOC121852957, LOC125316808, LOC125316809, LOC125316810, LOC125316811, LOC125316812, LOC125316813, LOC125316814, LOC125316815, LOC125316816, LOC125316817, LOC125316818, LOC125316819, LOC125316821, LOC125316822, LOC125316823, LOC126862658, LOC126862659, LOC126862660, LOC126862661, LOC126862662, LOC126862663, LOC126862664, LOC126862665, LOC126862666, LOC126862667, LOC126862668, LOC126862669, LOC126862670, LOC126862671, LOC126862672, LOC126862673, LOC126862674, LOC400627, LRRC45, MAFG, MCRIP1, METRNL, MILIP, MIR1250, MIR1268B, MIR3065, MIR3186, MIR338, MIR4525, MIR4730, MIR4739, MIR4740, MIR657, MIR6786, MIR6787, MRPL12, MYADML2, NARF, NARF-AS2, NDUFAF8, NOTUM, NPB, NPLOC4, NPTX1, OGFOD3, OXLD1, P4HB, PCYT2, PDE6G, PPP1R27, PVALEF, PYCR1, RAB40B, RAC3, RBFOX3, RFNG, RNF213, RNF213-AS1, RPTOR, SECTM1, SGSH, SIRT7, SLC16A3, SLC25A10, SLC26A11, SLC38A10, SNORD134, TBC1D16, TBCD, TEPSIN, TEX19, TIMP2, TMEM105, TRX-CAT1-8, TSPAN10, UTS2R, WDR45B, ZNF750 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr17:76914732-80978971
- GRCh38:
- Chr17:78918650-83021095
| SLC26A11, SLC38A10, SNORD134, TBC1D16, TBCD, TEPSIN, TEX19, TIMP2, TMEM105, TRX-CAT1-8, TSPAN10, UTS2R, WDR45B, ZNF750, AATK, ACTG1, ALYREF, ANAPC11, ARHGDIA, ARL16, ASPSCR1, B3GNTL1, BAHCC1, BAIAP2, BAIAP2-DT, C1QTNF1, C1QTNF1-AS1, CANT1, CARD14, CBX2, CBX4, CBX8, CCDC137, CCDC40, CCDC57, CD7, CENPX, CEP131, CHMP6, CSNK1D, CYBC1, DCXR, DCXR-DT, DUS1L, EIF4A3, ENDOV, ENGASE, ENPP7, FAAP100, FASN, FN3K, FN3KRP, FOXK2, FSCN2, GAA, GCGR, GPS1, HEXD, HEXD-IT1, HGS, LGALS3BP, LINC00482, LINC01970, LINC01971, LINC01977, LINC01978, LINC01979, LINC02078, LINC03048, LOC101928855, LOC101929552, LOC105371925, LOC108254691, LOC108281162, LOC108348028, LOC112533676, LOC112533677, LOC112533678, LOC112533679, LOC112533680, LOC112533681, LOC112533682, LOC112533686, LOC112533687, LOC116276483, LOC116276484, LOC116276485, LOC121627816, LOC121627817, LOC121627818, LOC121627819, LOC121627820, LOC121852953, LOC121852954, LOC121852955, LOC121852956, LOC121852957, LOC125316808, LOC125316809, LOC125316810, LOC125316811, LOC125316812, LOC125316813, LOC125316814, LOC125316815, LOC125316816, LOC125316817, LOC125316818, LOC125316819, LOC125316821, LOC125316822, LOC125316823, LOC126862658, LOC126862659, LOC126862660, LOC126862661, LOC126862662, LOC126862663, LOC126862664, LOC126862665, LOC126862666, LOC126862667, LOC126862668, LOC126862669, LOC126862670, LOC126862671, LOC126862672, LOC126862673, LOC126862674, LOC400627, LRRC45, MAFG, MCRIP1, MILIP, MIR1250, MIR1268B, MIR3065, MIR3186, MIR338, MIR4525, MIR4730, MIR4739, MIR4740, MIR657, MIR6786, MIR6787, MRPL12, MYADML2, NARF, NARF-AS2, NDUFAF8, NOTUM, NPB, NPLOC4, NPTX1, OGFOD3, OXLD1, P4HB, PCYT2, PDE6G, PPP1R27, PVALEF, PYCR1, RAB40B, RAC3, RBFOX3, RFNG, RNF213, RNF213-AS1, RPTOR, SECTM1, SGSH, SIRT7, SLC16A3, SLC25A10 | | See cases | Pathogenic (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78071052
- GRCh38:
- Chr17:80097253
| CCDC40, GAA | | not specified, not provided, Glycogen storage disease, type II, Primary ciliary dyskinesia, Primary ciliary dyskinesia 15 | Benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78073355
- GRCh38:
- Chr17:80099556
| CCDC40, GAA | | not specified, not provided, Primary ciliary dyskinesia, Primary ciliary dyskinesia 15, Glycogen storage disease, type II | Benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78073357
- GRCh38:
- Chr17:80099558
| CCDC40, GAA | R1071H | Primary ciliary dyskinesia 15, Glycogen storage disease, type II | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78073485
- GRCh38:
- Chr17:80099686
| GAA, CCDC40 | V1114M | not specified, not provided, Glycogen storage disease, type II, Primary ciliary dyskinesia, Primary ciliary dyskinesia 15 | Benign/Likely benign (Oct 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78073562
- GRCh38:
- Chr17:80099763
| CCDC40, GAA | | not provided, Primary ciliary dyskinesia, Glycogen storage disease, type II, not specified, Primary ciliary dyskinesia 15 | Benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78073589
- GRCh38:
- Chr17:80099790
| GAA, CCDC40 | | not specified, not provided, Primary ciliary dyskinesia, Primary ciliary dyskinesia 15, Glycogen storage disease, type II | Benign (Jul 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78073723
- GRCh38:
- Chr17:80099924
| CCDC40, GAA | | Primary ciliary dyskinesia, Primary ciliary dyskinesia 15, not provided, Glycogen storage disease, type II | Benign (Jul 9, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78073760
- GRCh38:
- Chr17:80099961
| CCDC40, GAA | | Primary ciliary dyskinesia, Primary ciliary dyskinesia 15, not provided, Glycogen storage disease, type II | Benign (Jul 9, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78073839
- GRCh38:
- Chr17:80100040
| CCDC40, GAA | | Primary ciliary dyskinesia 15, not provided, Primary ciliary dyskinesia, Glycogen storage disease, type II | Benign/Likely benign (Dec 31, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78074228
- GRCh38:
- Chr17:80100429
| CCDC40, GAA | | Primary ciliary dyskinesia, Primary ciliary dyskinesia 15, Glycogen storage disease, type II
| Benign/Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78075228
- GRCh38:
- Chr17:80101429
| GAA | | not provided | Benign (Jun 29, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78075247
- GRCh38:
- Chr17:80101448
| GAA | | not provided | Likely benign (Aug 10, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78075361
- GRCh38:
- Chr17:80101562
| GAA | | not provided | Likely benign (Aug 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78075384
- GRCh38:
- Chr17:80101585
| CCDC40, GAA | | not provided, Primary ciliary dyskinesia, Glycogen storage disease, type II
| Benign/Likely benign (May 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78075397
- GRCh38:
- Chr17:80101598
| CCDC40, GAA | | Primary ciliary dyskinesia 15, Glycogen storage disease, type II | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78075405
- GRCh38:
- Chr17:80101606
| GAA | | not specified | Likely benign (Dec 11, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78075410
- GRCh38:
- Chr17:80101611
| GAA | | not specified, Glycogen storage disease, type II | Conflicting interpretations of pathogenicity (Jan 22, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:78075438
- GRCh38:
- Chr17:80101639
| GAA | | not specified | Likely benign (May 8, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78075462
- GRCh38:
- Chr17:80101663
| GAA, CCDC40 | | Primary ciliary dyskinesia, not provided, Glycogen storage disease, type II
| Benign/Likely benign (Jun 29, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78075486
- GRCh38:
- Chr17:80101687
| GAA | | Glycogen storage disease, type II | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78075544
- GRCh38:
- Chr17:80101745
| CCDC40, GAA | | not provided, Primary ciliary dyskinesia, Glycogen storage disease, type II
| Benign/Likely benign (May 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78075606
- GRCh38:
- Chr17:80101807
| GAA | | not provided, Glycogen storage disease, type II | Conflicting interpretations of pathogenicity (May 13, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:78075618
- GRCh38:
- Chr17:80101819
| GAA | | not specified | Likely benign (Jan 26, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78075619
- GRCh38:
- Chr17:80101820
| GAA | | not provided | Likely benign (Jun 5, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78075647
- GRCh38:
- Chr17:80101848
| CCDC40, GAA | | not provided, Primary ciliary dyskinesia 15, Glycogen storage disease, type II
| Likely benign (Mar 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78075660
- GRCh38:
- Chr17:80101861
| GAA | | Glycogen storage disease, type II | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78075685
- GRCh38:
- Chr17:80101886
| GAA | | not specified | Likely benign (Oct 7, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78075706
- GRCh38:
- Chr17:80101907
| GAA | | not specified | Likely benign (Mar 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78075908
- GRCh38:
- Chr17:80102109
| GAA | | not provided | Benign (Jul 3, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078173
- GRCh38:
- Chr17:80104374
| GAA | | not provided | Likely benign (Jun 16, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078270
- GRCh38:
- Chr17:80104471
| GAA | | not provided | Likely benign (Jul 14, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078336
- GRCh38:
- Chr17:80104537
| GAA | | Glycogen storage disease type II, infantile | Uncertain significance (Feb 19, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078337-78078344
- GRCh38:
- Chr17:80104538-80104545
| GAA | | Glycogen storage disease, type II | Likely pathogenic (Oct 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078341
- GRCh38:
- Chr17:80104542
| GAA | | not specified, Glycogen storage disease, type II | Uncertain significance (Feb 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78078341-78093140
- GRCh38:
- Chr17:80104542-80119341
| GAA | | Glycogen storage disease, type II | Uncertain significance (Oct 29, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078341-78093150
- GRCh38:
- Chr17:80104542-80119351
| GAA | | Glycogen storage disease, type II | Uncertain significance (Oct 14, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078341-78079713
- GRCh38:
- Chr17:80104542-80105914
| GAA | | Glycogen storage disease, type II | Pathogenic (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078341
- GRCh38:
- Chr17:80104542
| GAA | | Cardiovascular phenotype, Inborn genetic diseases, Glycogen storage disease due to acid maltase deficiency, late-onset, not provided, Glycogen storage disease, type IV, Myopathy, Glycogen storage disease, type II | Pathogenic (Jan 11, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78078349
- GRCh38:
- Chr17:80104550
| GAA | | not provided | Uncertain significance (Sep 9, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078349
- GRCh38:
- Chr17:80104550
| GAA | | not provided | Likely benign (Jun 7, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078350
- GRCh38:
- Chr17:80104551
| GAA | | not specified | Likely benign (Feb 11, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078351
- GRCh38:
- Chr17:80104552
| GAA | | Glycogen storage disease, type II | Uncertain significance (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078351
- GRCh38:
- Chr17:80104552
| GAA | | Glycogen storage disease, type II | Uncertain significance (Jan 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078351
- GRCh38:
- Chr17:80104552
| GAA | | Glycogen storage disease, type II | Pathogenic/Likely pathogenic (Jul 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78078352
- GRCh38:
- Chr17:80104553
| GAA | | Glycogen storage disease, type II | Pathogenic/Likely pathogenic (Feb 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78078353
- GRCh38:
- Chr17:80104554
| GAA | | Glycogen storage disease, type II | Likely pathogenic (Jan 24, 2020) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:78078368
- GRCh38:
- Chr17:80104569
| GAA | | not provided | Likely benign (Dec 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078377
- GRCh38:
- Chr17:80104578
| GAA | | not provided | Likely benign (Jun 19, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078384
- GRCh38:
- Chr17:80104585
| GAA | | not specified, not provided | Benign/Likely benign (Jul 30, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78078386
- GRCh38:
- Chr17:80104587
| GAA | M1L | Glycogen storage disease, type II | Likely pathogenic (Jun 16, 2020) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:78078386
- GRCh38:
- Chr17:80104587
| GAA | M1V | Glycogen storage disease, type II | Pathogenic/Likely pathogenic (May 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78078387
- GRCh38:
- Chr17:80104588
| GAA | M1T | Glycogen storage disease, type II | Likely pathogenic (Jun 16, 2020) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:78078388-78078389
- GRCh38:
- Chr17:80104589-80104590
| GAA | | not provided | Pathogenic (Oct 22, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078388
- GRCh38:
- Chr17:80104589
| GAA | M1I | Glycogen storage disease, type II | Likely pathogenic (Jun 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78078389
- GRCh38:
- Chr17:80104590
| GAA | G2* | Glycogen storage disease, type II | Likely pathogenic (Mar 10, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:78078390
- GRCh38:
- Chr17:80104591
| GAA | G2A | Glycogen storage disease, type II, not provided | Uncertain significance (Feb 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78078393
- GRCh38:
- Chr17:80104594
| GAA | V3A | Glycogen storage disease, type II | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078396
- GRCh38:
- Chr17:80104597
| GAA | R4K | not provided, Glycogen storage disease, type II | Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78078401
- GRCh38:
- Chr17:80104602
| GAA | P6S | Glycogen storage disease, type II | Uncertain significance (Sep 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078402
- GRCh38:
- Chr17:80104603
| GAA | P6Q | Glycogen storage disease, type II | Uncertain significance (Mar 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078402
- GRCh38:
- Chr17:80104603
| GAA | P6L | not provided, Glycogen storage disease, type II | Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78078403
- GRCh38:
- Chr17:80104604
| GAA | | not provided, Glycogen storage disease, type II | Conflicting interpretations of pathogenicity (Jun 22, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:78078403
- GRCh38:
- Chr17:80104604
| GAA | | not provided, Glycogen storage disease, type II | Conflicting interpretations of pathogenicity (Feb 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:78078406
- GRCh38:
- Chr17:80104607
| GAA | | Glycogen storage disease, type II | Likely benign (Jun 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078409
- GRCh38:
- Chr17:80104610
| GAA | | Glycogen storage disease, type II | Likely benign (Aug 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078410
- GRCh38:
- Chr17:80104611
| GAA | S9P | not provided | Uncertain significance (Oct 2, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078411
- GRCh38:
- Chr17:80104612
| GAA | S9F | Glycogen storage disease, type II | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078411
- GRCh38:
- Chr17:80104612
| GAA | S9C | not provided | Uncertain significance (Jun 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078416
- GRCh38:
- Chr17:80104617
| GAA | R11W | Glycogen storage disease, type II | Uncertain significance (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078416
- GRCh38:
- Chr17:80104617
| GAA | R11G | Glycogen storage disease, type II | Uncertain significance (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078417
- GRCh38:
- Chr17:80104618
| GAA | R11L | Glycogen storage disease, type II | Uncertain significance (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078417
- GRCh38:
- Chr17:80104618
| GAA | R11Q | not specified, not provided, Glycogen storage disease, type II
| Conflicting interpretations of pathogenicity (Oct 30, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:78078421
- GRCh38:
- Chr17:80104622
| GAA | | Glycogen storage disease, type II, Cardiovascular phenotype | Conflicting interpretations of pathogenicity (Sep 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:78078422-78078429
- GRCh38:
- Chr17:80104623-80104630
| GAA | A14fs | Glycogen storage disease, type II | Pathogenic (Feb 7, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:78078426
- GRCh38:
- Chr17:80104627
| GAA | A14V | Glycogen storage disease, type II | Uncertain significance (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078427
- GRCh38:
- Chr17:80104628
| GAA | | Glycogen storage disease, type II | Likely benign (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078427
- GRCh38:
- Chr17:80104628
| GAA | | Glycogen storage disease, type II | Likely benign (Apr 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078428
- GRCh38:
- Chr17:80104629
| GAA | V15I | Glycogen storage disease, type II | Uncertain significance (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078433
- GRCh38:
- Chr17:80104634
| GAA | | Glycogen storage disease, type II | Likely benign (Jun 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078434
- GRCh38:
- Chr17:80104635
| GAA | A17S | Glycogen storage disease, type II | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078434
- GRCh38:
- Chr17:80104635
| GAA | A17T | Glycogen storage disease, type II | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078437
- GRCh38:
- Chr17:80104638
| GAA | L18F | Glycogen storage disease, type II | Uncertain significance (Jul 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078439
- GRCh38:
- Chr17:80104640
| GAA | | Glycogen storage disease, type II | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078439
- GRCh38:
- Chr17:80104640
| GAA | | Glycogen storage disease, type II | Uncertain significance (Sep 16, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78078440
- GRCh38:
- Chr17:80104641
| GAA | V19M | Cardiovascular phenotype, Glycogen storage disease, type II | Uncertain significance (Oct 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78078440
- GRCh38:
- Chr17:80104641
| GAA | V19fs | Glycogen storage disease, type II | Likely pathogenic (Mar 10, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr17:78078443
- GRCh38:
- Chr17:80104644
| GAA | S20T | Glycogen storage disease, type II | Uncertain significance (Mar 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078444
- GRCh38:
- Chr17:80104645
| GAA | S20C | not provided, Glycogen storage disease, type II | Uncertain significance (Oct 28, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78078452
- GRCh38:
- Chr17:80104653
| GAA | T23A | not provided, Glycogen storage disease, type II | Conflicting interpretations of pathogenicity (Nov 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:78078453
- GRCh38:
- Chr17:80104654
| GAA | T23I | Glycogen storage disease, type II | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078454
- GRCh38:
- Chr17:80104655
| GAA | | Cardiovascular phenotype, Glycogen storage disease, type II | Conflicting interpretations of pathogenicity (Dec 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr17:78078454
- GRCh38:
- Chr17:80104655
| GAA | | Glycogen storage disease, type II | Likely benign (Oct 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078455
- GRCh38:
- Chr17:80104656
| GAA | A24T | not provided, Glycogen storage disease, type II, Cardiovascular phenotype
| Uncertain significance (Aug 15, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr17:78078457
- GRCh38:
- Chr17:80104658
| GAA | | Glycogen storage disease, type II | Likely benign (Feb 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr17:78078459
- GRCh38:
- Chr17:80104660
| GAA | A25V | not provided, Glycogen storage disease, type II | Uncertain significance (Aug 30, 2021) | criteria provided, multiple submitters, no conflicts |